No recent analyst price targets found for BIOAF.
Latest News for BIOAF
Financial Analysis: Prelude Therapeutics (NASDAQ:PRLD) versus Bioasis Technologies (OTCMKTS:BIOAF)
Prelude Therapeutics (NASDAQ: PRLD - Get Free Report) and Bioasis Technologies (OTCMKTS:BIOAF - Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation and risk. Institutional and Insider Ownership 79.7% of Prelude Therapeutics
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for BIOAF.
Senate Trading
No Senate trades found for BIOAF.
U.S. House Trading
No House trades found for BIOAF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.